Furthermore, compared to DS individuals who were both amyloid and tau PET negative, those with amyloid PET–positive but tau‐negative scans, as well as those with both amyloid and tau PET–positive scans, exhibited significantly higher plasma t‐tau levels. This evidence concerns the gene MAPT and amyloidosis.